On July 1, 2014, FDA’s Center for Drug Evaluation and Research Small Business and Industry Assistance (CDER SBIA) will host a webinar designed to help manufacturers, repackagers, wholesale distributors, and dispensers identify suspect products.
On July 1, 2014, FDA’s Center for Drug Evaluation and Research Small Business and Industry Assistance (CDER SBIA) will host a webinar designed to help manufacturers, repackagers, wholesale distributors, and dispensers identify suspect products.
The webinar is entitled: “An Overview of FDA’s Draft Guidance - Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification.” It will begin at 1 pm EST.
“These focused webinars support the CDER SBIA’s mission of promoting productive interaction with regulated industry by assisting small pharmaceutical business and industry with information relating to the development and regulation of human drug products,” FDA wrote. “The purpose of this webinar is to provide an introduction and overview of FDA’s recently issued draft guidance….This is the first guidance issued under the Drug Supply Chain Security Act.”
The webinar’s featured speaker will be Carolyn Becker, a senior regulatory counsel in the FDA’s office of compliance.
Click here to register for the webinar.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.